Tian Yuan’s PRC and Hong Kong teams jointly advised Wuhan Dazhong Dental Medical Co., Ltd. (“Dazhong Dental”) on its IPO and listing on the Hong Kong Stock Exchange Main Board on July 9, 2025. Dazhong Dental is the first H-share listed chain medical group under China’s filing-based regulatory regime. Haitong International acted as the sole sponsor, global coordinator, and bookrunner, with Livermore Securities among other underwriters. 

 

Dazhong Dental, founded in 2007, is a chain healthcare group specializing in oral health services, committed to providing reliable and accessible dental care to communities while serving the general public. Currently, the group operates 4 for-profit dental hospitals, 80 for-profit dental outpatient centers, and 8 for-profit dental clinics, with an annual patient volume exceeding 700,000 visits. According to Frost & Sullivan, by revenue in 2024, Dazhong Dental ranked as the leading private dental service provider in Central China.

 

Tian Yuan’s Hong Kong and PRC teams served as the Company’s Hong Kong and PRC legal counsel, respectively, leveraging cross-border collaboration to deliver end-to-end legal support. The Hong Kong team drafted the prospectus, earning unanimous acclaim, while the PRC team streamlined regulatory compliance and facilitated communication with authorities, completing the CSRC filing process within seven months. Dazhong Dental’s listing underscores Tian Yuan’s integrated cross-border capabilities, particularly in healthcare capital markets. 

 

The Hong Kong team was led by Managing Partner Nan Li, with Partners Isabelle Wu and Crystal Zhang, Consultant Sean Ge, and Associates Hangyu Li, Junhao Fu, and Fuhua Deng. The PRC team was led by Partner Han Li, including Partner Wei Zhao and Associates Zongkai Hou, Ziqian Jiang, Bailu Han, and Shuli Zhang.